An Investigator And Subject-Blind, Phase 1 Study To Characterize The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Multiple Doses Of PF-04447943 In Healthy Elderly Subjects.

Trial Profile

An Investigator And Subject-Blind, Phase 1 Study To Characterize The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Multiple Doses Of PF-04447943 In Healthy Elderly Subjects.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 23 Feb 2009

At a glance

  • Drugs PF 4447943 (Primary)
  • Indications Cognition disorders
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 23 Feb 2009 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.
    • 29 Jan 2009 Actual patient numbers (10) added as reported by ClinicalTrials.gov.
    • 29 Jan 2009 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top